Skip to main content
SpringerLink
Log in

Toward Evidence-Based Chinese Medicine: Status Quo, Opportunities and Challenges

  • Perspective
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

How to test the treatments of Chinese medicine (CM) and make them more widely accepted by practitioners of Western medicine and the international healthcare community is a major concern for practitioners and researchers of CM. For centuries, various approaches have been used to identify and measure the efficacy and safety of CM. However, the high-quality evidence related to CM that produced in China is still rare. Over the recent years, evidence-based medicine (EBM) has been increasingly applied to CM, strengthening its theoretical basis. This paper reviews the past and present state of CM, analyzes the status quo, challenges and opportunities of basic research, clinical trials, systematic reviews, clinical practice guidelines and clinical pathways and evidence-based education developed or conducted in China, pointing out how EBM can help to make CM more widely used and recognized worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Group EBMW. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA 1992;268:2420–2425.

    Article  Google Scholar 

  2. Wang J. Evidence-based medicine in China. The Lancet 2010; 375:532–533.

    Article  Google Scholar 

  3. Li YP, Li J, Sun X, Liu M, Zhang MM, Du L, et al. The origin and development of evidence-based medicine in China: The 20th anniversary of the Introduction of evidence-based medicine to China. Chin J Evid-Based Med (Chin) 2016;16:2–6.

    Google Scholar 

  4. Lu DD, Xu F. Chinese medicine and evidence-based medicine. Med Philoy (Chin) 2001;22:57–58.

    CAS  Google Scholar 

  5. Li YP, Liu M. Evidence-based medicine and modernization of traditional Chinese medicine. Chin J Infor Chin Med (Chin) 1999;6:14–16.

    Google Scholar 

  6. Zhang BL. Differentiation of symptoms and prescription of treatment and evidence-based medicine. Chin J Evid-Based Med (Chin) 2002;2:1–3.

    Google Scholar 

  7. Zhang SH, Chen ZH. Application of evidence-based medicine in Chinese medicine. Study J Tradit Chin Med (Chin) 2002;20:357–362.

    Google Scholar 

  8. Wang YY, Liu BY, Xie YM. Establishing appraisal mechanism of clinial studies in traditional Chinese medicine with proofing medicine methodology. Chin J Basic Med Tradit Chin Med (Chin) 2003;9:17–23.

    Google Scholar 

  9. Sheng MX. Prospect of clinical research and practice of Chinese medicines by method of EBM. Chin J Tradit Chin Med Pharm (Chin) 2003;18:485–486.

    Google Scholar 

  10. Ni W, Li J. Evidence-based medicine and research of traditional Chinese medicine and pharmacology. China J Tradit Chin Med Pharm (Chin) 2002;17:644–645.

    Google Scholar 

  11. Li N, Guo J, Wang P, Bai FL. Activator to the study of traditional Chinese medicine:method of evidence-based medicine. J Evid Based Med 2003;3:34–36.

    CAS  Google Scholar 

  12. Lai S, Hu JQ, Guo X. Evidence-based medicine and clinical studies of traditional Chinese medicine. J Guangzhou Univer Tradit Chin Med (Chin) 2000;17:1–8.

    Google Scholar 

  13. Fei F, Zhong NS. From the point of research on the prevention and treatment of influenza to see the road of traditional Chinese medicine. Chin Med Pharm (Chin) 2015;5:1–3.

    Google Scholar 

  14. Fei F, Liu SS, Zhang BL. Promote the internationalization of traditional Chinese medicine research by evidence-based medicine. Chin Med Pharm (Chin) 2015;5:1–3.

    Google Scholar 

  15. Chen KJ, Qian ZH, Zhang WQ, Guan WR, Hao XG, Chen XJ, et al. Curative effect analysis of 112 cases of angina pectoris of coronary heart disease with refined coronal slice by double blind method. Bull Med Res (Chin) 1982;11:24–25.

    Google Scholar 

  16. Tang JL, Zhan SY, Ernst E. Review of randomised controlled trials of traditional Chinese medicine. BMJ 1999;319:160–161.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lu Z, Kou W, Du B, Wu Y, Zhao S, Brusco OA, et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial Infarction. Am J Cardiol 2008;101:1689–1693.

    Article  PubMed  Google Scholar 

  18. Li X, Zhang J, Huang J, Ma A, Yang J, Li W, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of Qili Qiangxin capsules in patients with chronic heart failure. J Am Coll Cardiol 2013;62:1065–1072.

    Article  PubMed  Google Scholar 

  19. Shang H, Zhang J, Yao C, Liu B, Gao X, Ren M, et al. Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. Evid Based Complement Alternat Med 2013;2013:738391.

    PubMed  PubMed Central  Google Scholar 

  20. Chen CLH, Young SHY, Gan HH, Singh R, Lao AY, Baroque AC 2nd, et al. Chinese medicine NeuroAID efficacy on stroke recovery: a double-blind, placebocontrolled, randomized study. Stroke 2013;44:2093–2100.

    Article  CAS  PubMed  Google Scholar 

  21. Lian F, Li G, Chen X, Wang X, Piao C, Wang J, et al. Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial. J Clin Endocrinol Metab 2014;99:648–655.

    Article  CAS  PubMed  Google Scholar 

  22. Wang C, Cao B, Liu QQ, Zou ZQ, Liang ZA, Gu L, et al. Oseltamivir compared with the Chinese traditional therapy Maxingshigan-Yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med 2011;155:217–225.

    Article  PubMed  Google Scholar 

  23. Zhu HH, Wu DP, Jin J, Li JY, Ma J, Wang JX, et al. Oral tetraarsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. J Clin Oncol 2013;31:4215–4221.

    Article  CAS  PubMed  Google Scholar 

  24. Phase III trial of Dantonic® (T89) capsule to prevent and treat stable angina (CAESA). Available at: https://clinicaltrials.gov/ct2/show/NCT01659580?term=T89&rank=2.

  25. Safety and efficacy of Kanglaite Gelcaps in prostate cancer. Available at: https://clinicaltrials.gov/ct2/show/NCT0148358 6?term=kanglaite&rank=4.

  26. Safety and exploratory efficacy of Kanglaite Injection in pancreatic cancer. Available at: https://clinicaltrials.gov/ct2/show/NCT00733850?term=Kanglaite&rank=3.

  27. Efficacy and safety study of lipid-lowering effects of XueZhiKang (XZK) in patients with hyperlipidemia. Available at: https://clinicaltrials.gov/ct2/show/NCT0132701 4?term=xuezhikang&rank=3.

  28. Assess the antifibrotic activity of Fuzheng Huayu in chronic hepatitis C patients with hepatic fibrosis. Available at: https://clinicaltrials.gov/ct2/show/NCT00854087?term=Fuzh eng+Huayu&rank=1.

  29. Phase II multi-center study of T89 to treat chronic stable angina (T89 phase 2). Available at: https://clinicaltrials.gov/ct2/show/NCT00797953?term=T89&rank=4.

  30. Treatment of primary menstrual pain with Kanion Capsule. Available at: https://clinicaltrials.gov/ct2/show/NCT0052314 6?term=Kanion+Capsule&rank=1.

  31. Hu CH. Clinical summary of the treatment of dysmenorrhea and irregular menstruation by concentrated Dangui Wan. Clin Pract 2004;22:394–398.

    Google Scholar 

  32. MEB annual report 2012. Available at: http://english.cbg-meb. nl/documents/annual-reports/2013/01/01/annual-report-2012.

  33. Lei X, Chen J, Liu CX, Lin J, Lou J, et al. Status and thoughts of Chinese patent medicines seeking approval in the US market. Chin J Integr Med 2014;20:403–408.

    Article  PubMed  Google Scholar 

  34. Wang C, Liu Q. A turning point for clinical research in China? Lancet 2013;382:835–836.

    Article  PubMed  Google Scholar 

  35. Moher SDD. Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM). Chin J Evid-Based Med (Chin) 2007;7:625–630.

    Google Scholar 

  36. STRICTA. Available at: http://www.stricta.info.

  37. Cheng CW, Fu SF, Wu TX, Shang HC, Tang XD, et al. Extending the CONSORT statement to moxibustion. J Integr Med 2013:54–63.

    Google Scholar 

  38. Wu T, Li Y, Bian Z, Liu G, Moher D. Randomized trials published in some Chinese journals: how many are randomized? Trials 2008;10:1–8.

    CAS  Google Scholar 

  39. Mao B, Wang G, Fan G, Chen T, Liu XD, Wang J, et al. Assessing the quality of reporting of randomized controlled trials in traditional Chinese medicine. Chin J Evid-Based Med (Chin) 2007;7:880–887.

    Google Scholar 

  40. Liu JP. Current state and countermeasures on quality of randomized controlled studies of traditional Chinese medicine. Chin J Integr Tradit West Med (Chin) 2003;23:62–64.

    Google Scholar 

  41. LI TQ, Wang G, Wang L, Bao B. Clinical trials of traditional Chinese medicine in China: status and evaluation. Chin J Evid Based Med (Chin) 2005;5:431–437.

    Google Scholar 

  42. He J, Liang D, Liu G, Fu J, He X, Yu J, et al. Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews. Trials 2011;12:286–298.

    Article  Google Scholar 

  43. Liu JP. Clinical research methodology for evidence-based Chinese medicine. Beijing: People’s Medical Publishing House;2006:93–102.

    Google Scholar 

  44. Evans D. Hierarchy of evidence: a framework for ranking evidence evaluating healthcare interventions. J Clin Nurs 2003;12:77–84.

    Article  PubMed  Google Scholar 

  45. Ueng TH, Kang JJ, Wang HW, Lin PC. An overview of the toxicology of commonly used traditional Chinese medicine. J Food Drug Anal 1997;5:241–263.

    CAS  Google Scholar 

  46. Chen Z, Li C, Liu S. Meta analysis on primary non-small cell lung carcinoma (NSCL) treated by TCM in China. J Tradit Chin Med (Chin) 1999;40:287–289.

    Google Scholar 

  47. Ernst E. Panax ginseng: An overview of the clinical evidence. J Ginseng Res 2010;34:259–263.

    Article  Google Scholar 

  48. Wei W, Zhu ZZ, Jiang D, Han R. A systematic review of the berberine in protecting kidneys of diabetic rats. China J Tradit Chin Med Pharm (Chin) 2013;1622–1626.

    Google Scholar 

  49. Wang JY, Tian GH, Zhang L, Mou W, Du L, Chen YL, et al. Systematic reviews of traditional Chinese medicine/current investigation of meta-analysis. J Lanzhou Univ (Med Sci, Chin) 2016;42:48–54.

    Google Scholar 

  50. Liu JP, Mcintosh H, Lin H. Chinese medicinal herbs for chronic hepatitis B. Cochrane Database Syst Rev 2001;7:CD001940.

    Google Scholar 

  51. Manheimer E, Windt Dvd, Udoff L, Haramati A, Langenberg P, Berman BM, et al. Effects of adjuvant acupuncture on pregnancy rates among women undergoing in vitro fertilization: systematic review and meta-analysis. BMJ 2008;336:545–549.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Fan WX, Zhong S, Liu F, Ye XF, Tu X, Huang SM. Astragalus combined with renin-angiotensin system (RAS)-inhibiting therapy for albuminuria in diabetic patients: a systematic review and meta-analysis of randomized trials. PROSPERO 2011: CRD42011001508. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record.asp? ID=CRD42011001508.

    Google Scholar 

  53. Chung VC, Wu X, Lu P, Hui EP, Zhang Y, Zhang AL, et al. Chinese herbal medicine for symptom management in cancer palliative care: systematic review and meta-analysis. PROSPERO 2015:CRD42015023931. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015023931.

    Google Scholar 

  54. Lau CH, Wu X, Chung VC, Liu X, Hui EP, Cramer H, et al. Acupuncture and related therapy for symptom management in palliative cancer care: systematic review and metaanalysis. Medicine (Baltimore) 2016;95:e2901.

    Article  Google Scholar 

  55. Qin ZS. Acupuncture for sciatica: a systematic review. PROSPERO 2014 CRD42014015001 Available at: http://www.crd.york.ac.uk/PROSPERO/display_record. php?ID=CRD42014015001.

    Google Scholar 

  56. Li X, Han M, Wang Y, Liu J. Chinese herbal medicine for gout: a systematic review and meta-analysis of randomized clinical trials. Clin Rheumatol 2013;32:943–959.

    Article  PubMed  Google Scholar 

  57. Luo J, Song W, Yang G, Xu H, Chen K. Compound Danshen (Salvia miltiorrhiza) Dripping Pill for coronary heart disease: an overview of systematic reviews. Am J Chin Med 2015;43:1–19.

    Article  Google Scholar 

  58. Shneerson C, Taskila T, Gale N, Greenfield S, Chen YF. The effect of complementary and alternative medicine on the quality of life of cancer survivors: a systematic review and meta-analyses. Complement Ther Med 2013;21:417–429.

    Article  PubMed  Google Scholar 

  59. Chung VC, Wu XY, Hui EP, Ziea ET, Ng BF, Ho RS, et al. Effectiveness and safety of adjuvant Chinese herbal medicine for cancer palliative care: overview of metaanalyses. PROSPERO 2015 CRD42015016171. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record. php?ID=CRD42015016171.

    Google Scholar 

  60. Wu X, Chung VC, Hui EP, Ziea ET, Ng BF, Ho RS, et al. Effectiveness of acupuncture and related therapies for cancer palliative care: overview of systematic reviews. Sci Rep 2015;5:16776.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Cheong KB, Zhang JP, Huang Y. The effectiveness of acupuncture in postoperative gastroparesis syndrome and postoperative ileus: a systematic review and metaanalysis. PROSPERO 2013 CRD42013005485. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record. php?ID=CRD42013005485.

    Google Scholar 

  62. Yang G, Wang Y, Xia Y, Tian J, Liu J. Huperzine A preparation for Alzheimer’s disease: a systematic review and meta-analysis of randomized clinical trials. PROSPERO 2012 CRD42012003249. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42012003249.

    Google Scholar 

  63. Ni X, Liu S, Lu F, Guo X, Shi X. Tai chi for Parkinson’s disease: a systematic review and meta-analysis. PROSPERO 2013 CRD42013004989. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42013004989.

    Google Scholar 

  64. Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 2002;252:107–113.

    Article  CAS  PubMed  Google Scholar 

  65. Ernst E. Adverse effects of herbal drugs in dermatology. Br J Dermatol 2000;143:923–929.

    Article  CAS  PubMed  Google Scholar 

  66. Ernst E. Adverse effects of unconventional therapies in the elderly: A systematic review of the recent literature. J Am Aging Assoc 2002;25:11–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Ernst E, Thompson CJ. Heavy metals in traditional Chinese medicines: a systematic review. Clin Pharmacol Ther 2001;70:497–504.

    Article  CAS  PubMed  Google Scholar 

  68. Fugh-Berman A, Ernst E. Herb–drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001;52:587–595.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Ernst E. Serious adverse effects of unconventional therapies for children and adolescents: a systematic review of recent evidence. Eur J Pediatr 2003;162:72–80.

    PubMed  Google Scholar 

  70. LI TQ, Liu XM, Zhang MM, Du L, Zhou YD, Chang J, et al. Assessment of systematic reviews and meta-analyses on traditional Chinese medicine published in Chinese journals. Chin J Evid-Based Med (Chin) 2007;7:180–188.

    Google Scholar 

  71. Chang YP. The quality of meta analysis and research related to medicine. J Prac Tradit Chin Inter Med (Chin) 2014;28:8–9.

    Google Scholar 

  72. Wei ML, Liu M, Wei S. The current status on systematic reviews/meta-analysis in Chinese publications from 1990-2007. West China Med J (Chin) 2007;22:697–698.

    Google Scholar 

  73. Dan HU, Kang DY, Wu YX. Methodological quality assessment of systematic reviews correlated to traditional Chinese medicine published in China. Chin J Integr Tradit West Med (Chin) 2011;31:402–406.

    Google Scholar 

  74. Liu JP, Xia Y. Quality appraisal of systematic reviews or metaanalysis on traditional Chinese medicine published in Chinese journals. Chin J Integr Tradit West Med (Chin) 2007;27:306–311.

    Google Scholar 

  75. Spence D. Evidence based medicine is broken. BMJ 2014;348:G22.

    Article  Google Scholar 

  76. Institute of Medicine. Clinical practice guidelines we can trust. Washington: The National Academies Press, 2011.

    Google Scholar 

  77. China Academy of Chinese Medical Sciences, China Association for Acupuncture and Moxibustion. Evidence-based guidelines of clinical practice in Chinese medicine: acupuncture. Beijing: China Press of Traditional Chinese Medicine, 2011:19–142.

  78. China Academy of Chinese Medical Sciences. Evidencebased guidelines of clinical practice in Chinese medicine: Internal Medicine. Beijing: China Press of Traditional Chinese Medicine 2011:1–434.

  79. China Academy of Chinese Medical Sciences. Evidencebased guidelines of clinical practice in Chinese medicine: specific disease. Beijing: China Press of Traditional Chinese Medicine;2011:1-148.

  80. Ya Y, Han X, Zhang H, Wang LY, Shi NN, Wang YY, et al. Study on quality assessment of TCM clinical practice guidelines based on AGREE instrument. World Sci Tech Modern Tradit Chin Med Mater Med (Chin) 2011;13:596–600.

    Google Scholar 

  81. Shi NN, Han XJ, Ya Y, Liu YQ, Wang YX, Wang LY, et al. Method of applicable adaptation of clinical practice guidelines and its inspiration on Chinese medicine clinical practice guidelines. Chin J Tradit Chin Med Pharm (Chin) 2014;10:3166–3169.

    Google Scholar 

  82. Wang LY, Zhao XY, Yu WY, Liu YQ, Wang YX, Liu MY, et al. Comparison of clinical practice guidelines with clinical pathways and diagnosis & treatment schemes in Chinese medicine. J Tradit Chin Med (Chin) 2015;56:2112–2115.

    Google Scholar 

  83. Zhao WT. Construction of "healthy China", fast pace of Chinese medicine. Available from: http://www.saCM.gov.cn/e/action/ShowInfo.php?classid=56&id=22057. html.

  84. Chen YL, Yang KH, Yao L, Tian JH, Bai ZG, Ma B. The development of GRADE systematic methodology. Chin J Evid-Based Med (Chin) 2013;8:1–2.

    CAS  Google Scholar 

  85. Planning and Finance Department of the State Administration of Traditional Chinese Medicine. The number of higher traditional Chinese medicine colleges, the number of higher institutions of Western medicine. Non-medical college in China In 2014. http://www.saCM.gov.cn/1999-2011/Abstracts of Chinese Medicine Statistics /atog/2014/C01.html.

  86. Developing and Planning Department of the Ministry of Education of the People’s Republic of China. Colleges and Universities set. http://old.moe.gov.cn/publicfiles/business/htmlfiles/moe/s181/index.html.

  87. The Ministry of Education of the People’s Republic of China (MOE). 2015 National Statistic for Institutions of Higher Education. http://old.moe.gov.cn/publicfiles/business/htmlfiles/moe/moe_229/201505/187754. html.

  88. Jin C, Liu GJ, LI J, Li W. A survey of evidence-based medicine teaching in China. Chin J Evid-Based Med (Chin) 2005;5:955–957.

    Google Scholar 

  89. Geng JS, Dong JC, Ni HJ. Impact of evidence-based medicine curriculum on medical students in China: a systematic review approach. China Higher Med Ed (Chin) 2012;3:43–45.

    Google Scholar 

  90. MA L, Jiang JG, Yu SX. Analysis of the perception level of clinicians on EBM. Modern Prev Med (Chin) 2008;35:2617–2619.

    Google Scholar 

  91. Dong BR, Ding QF. Investigating the awareness and application of EBM in the clinical practice. West China Med J (Chin) 2000;15:125–127.

    Google Scholar 

  92. Liu B. A primary survey of evidence-based medicine and traditional Chinese medicine. Chin J Evid-Based Med (Chin) 2004;19:44–49.

    Google Scholar 

  93. Shang HC, Zhang BL. Country-led, multi-stakeholder involvement, and jointly promote the overall level of CM clinical research. Chin Evid-Based Med (Chin) 2010;10:640–641.

    Google Scholar 

  94. Shang HC, Zhang BL, Wang YY. Clinical research of traditional Chinese medicine needs "a breakthrough". Tianjin J Tradit Chin Med (Chin) 2013;30:4–5.

    Google Scholar 

  95. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol 2010;63:1308–1311.

    Article  PubMed  Google Scholar 

  96. Schünemann HJ, Wiercioch W, Etxeandia I, Falavigna M, Santesso N, Mustafa R, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ 2014;186:123–142.

    Article  Google Scholar 

  97. Chen Y, Yang K, Marušic A, Qaseem A, Meerpohl JJ, Flottorp S, et al. A reporting tool for practice guidelines in health care: The RIGHT statement. Ann Intern Med 2017;166:128–132.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Janne Estill for his valuable comments and revisions on an earlier draft of this manuscript.

Author information

Authors and Affiliations

  1. Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100007, China

    Yao-long Chen & Hong-cai Shang

  2. Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, China

    Yao-long Chen & Ke-hu Yang

  3. Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, 730000, China

    Yao-long Chen & Ke-hu Yang

  4. Chinese GRADE Center, Lanzhou, 730000, China

    Yao-long Chen & Ke-hu Yang

  5. China School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, 999077, China

    Chen Zhao & Zhao-xiang Bian

  6. Department of Clinical Pharmacology, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China

    Li Zhang & Wei Mu

  7. Department of Gastroenterology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100091, China

    Bo Li

  8. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China

    Chuan-hong Wu

  9. Department of Acupuncture and Moxibustion, Wuxi People’s Hospital, Jiangsu, 214023, China

    Jia-ying Wang

  10. Chinese Cochrane Centre, West China Hospital, Sichuan University, Chengdu, 610041, China

    You-ping Li

  11. Division of Plastic Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, 106, China

    Chiehfeng Chen

  12. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China

    Yong-yan Wang

  13. Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, 100029, China

    Chen Wang

Authors
  1. Yao-long Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chen Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Li Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bo Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chuan-hong Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wei Mu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jia-ying Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ke-hu Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. You-ping Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Chiehfeng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yong-yan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Chen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Zhao-xiang Bian
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Hong-cai Shang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hong-cai Shang.

Additional information

Supported by the National Natural Science Foundation of China (No. 81430098, 81273935, 81503459)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, Yl., Zhao, C., Zhang, L. et al. Toward Evidence-Based Chinese Medicine: Status Quo, Opportunities and Challenges. Chin. J. Integr. Med. 24, 163–170 (2018). https://doi.org/10.1007/s11655-017-2795-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-017-2795-2

Keywords

Search

Navigation